Security Snapshot

vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) Institutional Ownership

CUSIP: 918385204

13F Institutional Holders and Ownership History from Q3 2023 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

35

Shares (Excl. Options)

1,487,273

Price

$39.66

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Class A Common Stock, par value $0.01 per share
Symbol
VTVT on Nasdaq
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
1,487,273
Latest holder snapshot 5 signals
Total 13F value
$58,986,362
Portfolio coverage rank
0%
Share change
+160,728
Value change
+$6,374,514
Number of holders
35
Security identity Names, identifiers, and filing context for this profile. 1 source field
Underlying class
Class A Common Stock ("Common Stock")
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
3,948,649
SEC-reported price per share
$31.04
Insider filing price
$31.04
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share is tracked under CUSIP 918385204.
  • 35 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 27 to 35 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $51,331,670 to $58,986,362.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 35 institutions filings for Q1 2026.

Open SEC evidence

Security key

918385204

Latest holder period

Q1 2026

13F holders

35

13D/G owners

4

CIK / CUSIP context first

Open Q1 2026 holders VTVT full holder history vTv Therapeutics Inc. SEC filings vTv Therapeutics Inc. company facts vTv Therapeutics Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
VTVT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Samsara BioCapital, L.P. 9.9% 0% $12,001,117 +$1,803,961 403,942 +18% Srinivas Akkaraju 08 Dec 2025
Invus Global Management, LLC 9.4% -5.9% $9,179,310 +$1,051,154 393,098 +13% Raymond Debbane 30 Sep 2025
Trails Edge Capital Partners, LP 9.9% $5,108,040 340,536 Trails Edge Capital Partners, LP 29 Aug 2025
MILLENNIUM MANAGEMENT LLC 5.7% +14% $8,927,903 +$1,064,496 225,073 +14% Millennium Management LLC 13 Apr 2026

As of 31 Mar 2026, 35 institutional investors reported holding 1,487,273 shares of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT). This represents 38% of the company’s total 3,948,649 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
38%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SAMSARA BIOCAPITAL, LLC 7.6% 298,496 0% 1.2% $11,838,351
FMR LLC 6.6% 260,391 -3.1% 0% $10,327,107
MILLENNIUM MANAGEMENT LLC 5.2% 206,288 0.01% $8,181,382
Siren, L.L.C. 4.1% 163,000 0% 0.18% $6,464,580
BAKER BROS. ADVISORS LP 3.8% 148,314 0% 0.03% $5,882,133
Trails Edge Capital Partners, LP 3.5% 139,578 -40% 1.3% $5,535,663
VANGUARD CAPITAL MANAGEMENT LLC 2.8% 108,922 0% 0% $4,319,847
GEODE CAPITAL MANAGEMENT, LLC 0.83% 32,886 +17% 0% $1,305,141
NORTHERN TRUST CORP 0.46% 18,052 +12% 0% $715,942
VANGUARD FIDUCIARY TRUST CO 0.41% 16,126 0% 0% $639,557
683 Capital Management, LLC 0.41% 16,000 -12% 0.06% $634,560
MARSHALL WACE, LLP 0.34% 13,389 0% $531,007
GOLDMAN SACHS GROUP INC 0.34% 13,350 +141% 0% $529,461
BlackRock, Inc. 0.32% 12,602 +19% 0% $499,795
STATE STREET CORP 0.27% 10,666 0% $423,014
Brevan Howard Capital Management LP 0.19% 7,531 0% $298,679
Pathstone Holdings, LLC 0.15% 6,073 0% 0% $240,872
UBS Group AG 0.14% 5,636 +238% 0% $223,524
Qube Research & Technologies Ltd 0.14% 5,618 0% $222,810
Vanguard Global Advisers, LLC 0.03% 1,275 0% 0% $50,567
MORGAN STANLEY 0.03% 1,155 +18% 0% $45,807
OSAIC HOLDINGS, INC. 0.03% 1,119 -0.09% 0% $44,379
Farther Finance Advisors, LLC 0.01% 283 +1.4% 0% $11,470
Strengthening Families & Communities, LLC 0% 173 0% $6,861
BESSEMER GROUP INC 0% 112 0% 0% $4,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
11
Latest
Q1 2026
Rows shown
1-11 of 11
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,487,273 $58,986,362 +$6,374,514 $39.66 35
2025 Q4 1,283,622 $51,331,670 +$2,953,481 $39.99 27
2025 Q3 988,279 $23,052,921 +$9,364,357 $23.35 23
2025 Q2 587,143 $8,742,344 +$226,154 $15.00 21
2025 Q1 571,712 $9,902,095 +$353,201 $17.32 20
2024 Q4 551,416 $7,570,090 +$133,643 $13.81 17
2024 Q3 542,324 $7,337,088 +$2,516,893 $13.56 20
2024 Q2 348,140 $6,148,038 +$252,272 $17.66 19
2024 Q1 333,650 $7,850,341 +$6,240,904 $23.53 19
2023 Q4 68,620 $788,715 +$781,835 $11.50 14
2023 Q3 600 $287 +$287 $0.48 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .